Literature DB >> 17725487

Role of DLX regulatory proteins in osteogenesis and chondrogenesis.

Nadeem Samee1, Marie-Christine de Vernejoul, Giovanni Levi.   

Abstract

Bone development is a complex process in which several cell types interact, proliferate, differentiate, and die to give rise to skeletal structures. These processes are highly integrated and require continuous and coordinated regulation by soluble molecular signals and transcription factors to assure harmonious bone development and morphogenesis. In the bone, transcription factors often have multiple functions and control the differentiation of more than one skeletal cellular component. In particular, Distal-less (Dlx) homeobox transcription factors play a central role in regulating the proliferation and differentiation of the three major cell types that constitute bone: chondrocytes, osteoblasts, and osteoclasts. The aim of this review is to summarize what is known about the role of Dlx genes in osteogenesis and to emphasize their role as coordinators at different levels of skeletal development. The elucidation of these unifying roles could improve our understanding not only of bone development but also of adult bone anabolism and catabolism resulting in bone homeostasis and might thus help to further our understanding of the genetic factors responsible for predisposition to multifactorial conditions such as osteoporosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17725487     DOI: 10.1615/critreveukargeneexpr.v17.i3.10

Source DB:  PubMed          Journal:  Crit Rev Eukaryot Gene Expr        ISSN: 1045-4403            Impact factor:   1.807


  15 in total

1.  Dlx genes and the maintenance of bone homeostasis and skeletal integrity.

Authors:  G Levi; Y Gitton
Journal:  Cell Death Differ       Date:  2014-09       Impact factor: 15.828

2.  Insulin-like growth factor-II regulates bone sialoprotein gene transcription.

Authors:  Jin Choe; Yoko Sasaki; Liming Zhou; Hideki Takai; Yohei Nakayama; Yorimasa Ogata
Journal:  Odontology       Date:  2015-04-21       Impact factor: 2.634

3.  Dlx5, a positive regulator of osteoblastogenesis, is essential for osteoblast-osteoclast coupling.

Authors:  Nadeem Samee; Valerie Geoffroy; Caroline Marty; Corinne Schiltz; Maxence Vieux-Rochas; Giovanni Levi; Marie-Christine de Vernejoul
Journal:  Am J Pathol       Date:  2008-07-31       Impact factor: 4.307

4.  Meningioma 1 is required for appropriate osteoblast proliferation, motility, differentiation, and function.

Authors:  Xiaoxue Zhang; Diane R Dowd; Meika C Moore; Tanya A Kranenburg; Magda A Meester-Smoor; Ellen C Zwarthoff; Paul N MacDonald
Journal:  J Biol Chem       Date:  2009-04-22       Impact factor: 5.157

5.  DLX3 regulates bone mass by targeting genes supporting osteoblast differentiation and mineral homeostasis in vivo.

Authors:  J Isaac; J Erthal; J Gordon; O Duverger; H-W Sun; A C Lichtler; G S Stein; J B Lian; M I Morasso
Journal:  Cell Death Differ       Date:  2014-06-20       Impact factor: 15.828

6.  DLX5 promotes osteosarcoma progression via activation of the NOTCH signaling pathway.

Authors:  Xiaojing Zhang; Huiqin Bian; Wei Wei; Qian Wang; Jinnan Chen; Ruoxuan Hei; Chen Chen; Xuan Wu; Haochun Yuan; Junxia Gu; Yaojuan Lu; Cheguo Cai; Qiping Zheng
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

7.  BMP-2 Induced Expression of Alx3 That Is a Positive Regulator of Osteoblast Differentiation.

Authors:  Takashi Matsumoto; Atsushi Yamada; Ryo Aizawa; Dai Suzuki; Masayuki Tsukasaki; Wataru Suzuki; Mutsuko Nakayama; Koutaro Maki; Matsuo Yamamoto; Kazuyoshi Baba; Ryutaro Kamijo
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

8.  Mutually exclusive expression of DLX2 and DLX5/6 is associated with the metastatic potential of the human breast cancer cell line MDA-MB-231.

Authors:  Monica Morini; Simonetta Astigiano; Yorick Gitton; Laura Emionite; Valentina Mirisola; Giovanni Levi; Ottavia Barbieri
Journal:  BMC Cancer       Date:  2010-11-25       Impact factor: 4.430

9.  GATA4 negatively regulates osteoblast differentiation by downregulation of Runx2.

Authors:  Insun Song; Kabsun Kim; Jung Ha Kim; Young-Kyoung Lee; Hyun-Jung Jung; Hae-Ok Byun; Gyesoon Yoon; Nacksung Kim
Journal:  BMB Rep       Date:  2014-08       Impact factor: 4.778

Review 10.  MicroRNAs and micromanaging the skeleton in disease, development and evolution.

Authors:  Xinjun He; Johann K Eberhart; John H Postlethwait
Journal:  J Cell Mol Med       Date:  2009-02-09       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.